Use of the Electronic Health Record for Monitoring Adverse Drug Reactions

被引：1
|
作者：
Muzaffar, Anum F. [1 ]
Abdul-Massih, Sandra [2 ]
Stevenson, James M. [2 ,4 ]
Alvarez-Arango, Santiago [2 ,3 ,4 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Allergy & Immunol, Baltimore, MD 21224 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Div Clin Pharmacol, Baltimore, MD 21224 USA
[3] Johns Hopkins Univ, Sch Med, Dept Med, Div Allergy & Clin Immunol, Hopkins Bayview Circle 5501, Baltimore, MD 21224 USA
[4] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21224 USA
来源：
CURRENT ALLERGY AND ASTHMA REPORTS | 2023年 / 23卷 / 07期
关键词：
Drug-related adverse reactions and allergies; Adverse drug reaction documentation; Electronic health records; Drug safety; Pharmacovigilance; Clinical decision support systems; IMPLEMENTATION CONSORTIUM GUIDELINES; PENICILLIN ALLERGY; B GENOTYPE; PHARMACOGENOMICS; DOCUMENTATION; PATIENT; SYSTEMS; PREDICT; CYP2C9;
D O I：
10.1007/s11882-023-01087-w
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Purpose of ReviewAdverse drug reactions (ADRs) are a significant cause of morbidity and mortality. The electronic health record (EHR) provides an opportunity to monitor ADRs, mainly through the utilization of drug allergy data and pharmacogenomics. This review article explores the current use of the EHR for ADR monitoring and highlights areas that require improvement.Recent FindingsRecent research has identified several issues with using EHR for ADR monitoring. These include the lack of standardization between EHR systems, specificity in data entry options, incomplete and inaccurate documentation, and alert fatigue. These issues can limit the effectiveness of ADR monitoring and compromise patient safety.The EHR has great potential for monitoring ADR but needs significant updates to improve patient safety and optimize care. Future research should concentrate on developing standardized documentation and clinical decision support systems within EHRs. Healthcare professionals should also be educated on the significance of accurate and complete ADR monitoring.
引用
收藏
页码：417 / 426
页数：10
相关论文
共 50 条
  • [41] The role of electronic records in reporting adverse drug reactions
    Poirier, Alanna M.
    Nachowicz, Paul
    Misra, Subhasis
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34)
  • [42] Implementation of Electronic Health Record Integration and Clinical Decision Support to Improve Emergency Department Prescription Drug Monitoring Program Use
    Hoppe, Jason A.
    Ledbetter, Caroline
    Tolle, Heather
    Heard, Kennon
    ANNALS OF EMERGENCY MEDICINE, 2024, 83 (01) : 3 - 13
  • [43] Pharmacogenetics, adverse drug reactions and public health
    Kollek, R
    van Aken, J
    Feuerstein, G
    Schmedders, M
    COMMUNITY GENETICS, 2006, 9 (01) : 50 - 54
  • [44] Patient Electronic Health Record as Temporal Graphs for Health Monitoring
    Le Baher, Hugo
    Aze, Jerome
    Bringay, Sandra
    Poncelet, Pascal
    Rodriguez, Nancy
    Dunoyer, Caroline
    CARING IS SHARING-EXPLOITING THE VALUE IN DATA FOR HEALTH AND INNOVATION-PROCEEDINGS OF MIE 2023, 2023, 302 : 561 - 565
  • [45] Discovering Novel Adverse Drug Events Using Natural Language Processing and Mining of the Electronic Health Record
    Friedman, Carol
    ARTIFICIAL INTELLIGENCE IN MEDICINE, PROCEEDINGS, 2009, 5651 : 1 - 5
  • [46] Coetaneous drug hypersensitivity reactions in database of the centre for adverse drug reactions monitoring in Cracow
    Porebski, G.
    Woron, J.
    Czarnobilska, E.
    Rembiasz, M.
    Antoszczyk, G.
    Obtulowicz, K.
    ALLERGY, 2008, 63 : 107 - 107
  • [47] Controlling adverse drug reactions through improved monitoring
    McDonnell, PJ
    AMERICAN JOURNAL OF MANAGED CARE, 2006, 12 (05): : 256 - 257
  • [48] The quality of information on monitoring for haematological adverse drug reactions
    Ferner, RE
    Coleman, J
    Pirmohamed, M
    Constable, SA
    Rouse, A
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 60 (04) : 448 - 451
  • [49] Standardized warfarin monitoring decreases adverse drug reactions
    Lisa B. E. Shields
    Paula Fowler
    Diane M. Siemens
    Douglas J. Lorenz
    Kenneth C. Wilson
    Steven T. Hester
    Joshua T. Honaker
    BMC Family Practice, 20
  • [50] A Kap Study of Adverse Drug Reactions Monitoring by Physicians
    Sen, Sukanta
    Banerjee, Indranil
    Pal, Agnik
    Biswas, Arunava
    Chatterjee, Dattatreyo
    Tripathi, Santanu K.
    INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 : S53 - S53
12345